Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-028819
Filing Date
2013-05-17
Accepted
2013-05-17 18:59:36
Documents
1
Period of Report
2013-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd380490.html 3  
1 FORM 3 rrd380490.xml 3 3756
  Complete submission text file 0001181431-13-028819.txt   5463
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address STARCO CENTER, BLOC B, THIRD FLOOR OMAR DAOUK STREET BEIRUT M8 2020-3313
Business Address STARCO CENTER, BLOC B, THIRD FLOOR OMAR DAOUK STREET BEIRUT M8 2020-3313 961 1 363 362
Pillar Pharmaceuticals III, L.P. (Reporting) CIK: 0001576891 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-31918 | Film No.: 13856412